The GCC implantable medical devices market size reached USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 1.6 Billion
Market Forecast in 2033	USD 2.8 Billion
Market Growth Rate 2025-2033	6.3%

IMARC Group provides an analysis of the key trends in each segment of the GCC implantable medical devices market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on product, material and end user.

UAE Wearable Medical Devices Market is anticipated to grow at a robust CAGR during the forecast period, 2024-2028. United Arab Emirates Wearable Medical Devices Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2028 By Type, By Products, By Purpose, By Site, By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2028

Pages	75
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

The Middle East and North Africa (MENA) medical device reprocessing market is experiencing robust growth, projected to reach a substantial size. The market's Compound Annual Growth Rate (CAGR) of 15.93% from 2019 to 2024 indicates significant expansion driven by factors such as increasing surgical procedures, rising prevalence of chronic diseases necessitating frequent medical device usage, and a growing emphasis on cost-effectiveness within healthcare systems. The adoption of advanced reprocessing technologies, improving sterilization techniques, and stringent regulatory frameworks promoting device safety contribute to this growth. The market segmentation reveals a higher demand for Class II devices, encompassing essential items like pulse oximeter sensors and catheters, reflecting the increasing complexity of medical procedures in the region. The GCC region, within the broader MENA landscape, currently holds a significant market share due to its advanced healthcare infrastructure and higher per capita healthcare spending. South Africa also represents a substantial market segment, showcasing growth opportunities driven by investments in healthcare infrastructure and rising medical tourism. However, challenges such as limited awareness regarding appropriate reprocessing practices, inconsistent regulatory enforcement across different MENA countries, and the high initial investment associated with advanced reprocessing equipment may hinder growth in certain sub-segments. The market is dominated by key players including Stryker, Johnson & Johnson, and Cardinal Health, with smaller, regional companies also actively participating. The foreseeable future suggests continued growth, propelled by government initiatives focused on improving healthcare infrastructure, investments in medical technology, and a heightened focus on infection control and patient safety. Further expansion will depend on addressing challenges related to infrastructure development, training healthcare professionals in proper reprocessing techniques, and creating a standardized regulatory environment across the diverse nations within the MENA region. Opportunities exist for innovative reprocessing technologies that address the unique challenges of the MENA region, such as adaptation to higher ambient temperatures and improved efficiency in resource-constrained settings. Companies focusing on developing user-friendly, cost-effective, and technologically advanced reprocessing solutions stand to benefit significantly from this market's upward trajectory. The long-term forecast suggests substantial market expansion, with the continued growth of the private healthcare sector, increasing medical tourism, and a sustained focus on improving healthcare access for the region's growing population. Recent developments include: June 2022: The Ministry of Health (MOH) launched a workshop in Oman on endoscope reprocessing in collaboration with WHO. The event involved an exhibition displaying state-of-the-art equipment and techniques for medical device reprocessing., March 2022: Getinge AB, a company focused on developing automated endoscope reprocessors, established a Getinge training center in Dubai on the premises of the medtech company's distributor, MPC Healthcare. In this center, visitors can experience and interact with the company's sterile reprocessing solutions.. Key drivers for this market are: Cost Savings Through Reprocessing Single-use Devices, Rising Need to Reduce the Volume of Medical Waste. Potential restraints include: Cost Savings Through Reprocessing Single-use Devices, Rising Need to Reduce the Volume of Medical Waste. Notable trends are: Catheters and Guidewires in the Class II Devices Segment are Anticipated to Grow Over the Forecast Period.

The GCC medical glove industry value is estimated to be around US$ 170.3 million in 2024 according to the updated industry analysis report. A growing focus on adequate hygiene practices in the healthcare sector is expected to continue boosting sales of medical gloves in the Gulf Cooperation Council region.

Report Attribute	Details
GCC Medical Glove Industry Size (2024)	US$ 170.3 million
Industry Anticipated Forecast Value (2034)	US$ 213.7 million
Industry Projected Growth Rate (2024 to 2034)	2.3% CAGR

GCC Medical Glove Sector Historical Analysis (2019 to 2023) Vs Forecast Outlook (2024 to 2034)

Attributes	Details
GCC Medical Glove Industry Value (2019)	US$ 152.1 million
Industry Revenue (2023)	US$ 167.1 million
Industry Historical Growth Rate (CAGR 2019 to 2023)	1.9% CAGR

Country-wise Insights

Regional Industry Comparison	CAGR (2024 to 2034)
Kingdom of Saudi Arabia	3.8%
United Arab Emirates (UAE)	4%
Qatar	3.2%
Kuwait	3.1%
Oman	2.9%

Category-wise Insights

Attributes	Details
Top Product Type or Segment	Disposable Examination Gloves
Industry Share in 2024	69%

Attributes	Details
Top End User Type or segment	Hospitals
Industry Share in 2024	49%

The size of the United Arab Emirates Drug Delivery Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 20.00% during the forecast period.The United Arab Emirates drug delivery devices market holds much promise in the context of this high prevalence of chronic diseases and the increasing geriatric population. It grows significantly due to increasing expenditure in the healthcare sector. Innovative drug delivery devices were specifically designed to deliver medicines at the target site itself for enhanced therapeutic efficacy while lowering the side effects caused. Such devices have total control over the release of the drug, which maximizes the dose while maintaining a minimal level of systemic exposure. The UAE is a promising drug delivery device market, particularly with a well-developed healthcare infrastructure and state of the art medical technology in the country. Demand in the country for drug delivery is increasing due to the continuously expanding population and the emerging awareness of health care services. This is furthered through the initiatives of the government pertaining to health care innovation and through foreign investments. The important segments under the umbrella of drug delivery devices in UAE are insulin delivery devices, inhalers, infusion pumps, and transdermal patches. The primary segments for insulin delivery devices mainly comprise pen injectors as well as insulin pumps which are experiencing a tremendous amount of growth because of high disease prevalence among the population due to diabetes. It is also going through a growth phase as individuals increasingly use inhalers during treatment for respiratory conditions that have been on an expansion spurt due to increasingly rising pollution levels within this country. Infusion pumps, which are used for the precise delivery of drugs, have applications in many therapies such as oncology and pain management. Transdermal patches in which drugs are released for longer periods are being increasingly applied as they are easy on the patient and convenient in nature. This, in turn, will push the growth of the market for drug delivery devices as the UAE focuses more on medical advancement. Emerging technologies like wearable drug delivery systems and implantable devices will likely lead to promising futures. Recent developments include: October 2022: Abu Dhabi Medical Devices Company, the Abu Dhabi Ports Group, and Abu Dhabi Polymers Company partnered with PureHealth, for AED 260 million (USD 70.79 million) to manufacture medical equipment, such as medical syringes, administration devices, and blood collection tubes, locally., June 2022: ADQ, an Abu Dhabi investment company, acquired Birgi Mefar Group (BMG) to boost the United Arab Emirates' ability to manufacture sterile injectable products such as vials and pre-filled syringes.. Key drivers for this market are: Rising Prevalence of Chronic Diseases and Growth in the Biologics Market, Increased Understanding of Drug Metabolism and Growing Requirement of Controlled Drug Release and Technological Advancements. Potential restraints include: High Cost of Development, Regulatory Concern and Risk of Needlestick Injuries. Notable trends are: Oral Segment Expects to Register a High CAGR in the United Arab Emirates Drug Delivery Devices Market Over the Forecast Period.

The Middle East and Africa (MEA) hospital supplies market is experiencing robust growth, driven by factors such as rising prevalence of chronic diseases, increasing healthcare expenditure, and government initiatives to improve healthcare infrastructure across the region. The market's Compound Annual Growth Rate (CAGR) of 8.30% from 2019 to 2024 indicates a significant expansion, and this momentum is expected to continue throughout the forecast period (2025-2033). Key segments within the MEA market include patient examination devices, operating room equipment, mobility aids, sterilization equipment, disposable supplies, and syringes and needles. The GCC countries, particularly Saudi Arabia and the UAE, are major contributors to market growth, driven by their advanced healthcare infrastructure and high per capita income. South Africa also represents a significant market due to its relatively developed healthcare system. However, challenges such as limited healthcare access in certain regions, economic disparities, and regulatory hurdles in some countries pose constraints to market growth. The market is highly competitive, with leading players such as 3M, GE Healthcare, B. Braun, BD, Baxter, Cardinal Health, Johnson & Johnson, Invacare, and Stryker actively vying for market share through product innovation, strategic partnerships, and expansion into untapped segments. The increasing adoption of advanced medical technologies and a rising preference for minimally invasive procedures are key trends shaping the market's future trajectory. The growth trajectory is influenced by several interconnected factors. Government investments in healthcare infrastructure and expansion of hospital networks across the MEA region are fostering market expansion. Furthermore, a burgeoning middle class with increasing disposable income is driving demand for higher-quality healthcare services, boosting the consumption of advanced hospital supplies. The prevalence of infectious diseases continues to be a major driver, especially in sub-Saharan Africa, fueling demand for sterilization and disinfection equipment and disposable supplies. However, inconsistent healthcare infrastructure, particularly in certain regions, and variations in regulatory landscapes across different MEA countries represent significant obstacles that manufacturers must navigate to successfully expand their market presence. A focus on improving access to quality healthcare across the region, combined with continued investment in healthcare technology, will ultimately determine the full potential of the MEA hospital supplies market in the coming years. Recent developments include: In May 2022, Aston University product design experts announced to help improve wheelchair design and manufacture in Africa. The project was a collaboration with the Central University of Technology in Bloemfontein, South Africa, In January 2022, Cedars-Sinai collaborated with Elegancia Healthcare, a division of Power International Holding, to plan a new, state-of-the-art hospital in Doha, Qatar, that is likely to be the nation's first private healthcare option. The 'View hospital' is scheduled to be complete in August and is likely to have 244 inpatient beds, including 12 intensive care unit beds, and 10 surgical suites.. Key drivers for this market are: Growth in the Spending on Healthcare, Increasing Occurrences of Communal Diseases and Hospital Acquired Infections. Potential restraints include: Growth in the Spending on Healthcare, Increasing Occurrences of Communal Diseases and Hospital Acquired Infections. Notable trends are: Operating Room Equipment Segment Expected to Hold Significant Market Share over the Forecast Period.

The Middle East and Africa (MEA) General Surgical Devices market is experiencing robust growth, projected to reach a significant market size by 2033. A Compound Annual Growth Rate (CAGR) of 11.80% from 2025 to 2033 indicates a substantial expansion driven by several key factors. Rising prevalence of chronic diseases necessitating surgical interventions, increasing disposable incomes leading to higher healthcare expenditure, and a growing geriatric population requiring more complex surgeries are major contributors to this growth. Furthermore, advancements in minimally invasive surgical techniques, such as laparoscopy, are driving demand for sophisticated surgical devices. The adoption of these technologies improves patient outcomes, reduces recovery times, and minimizes hospital stays, positively impacting both healthcare providers and patients. Technological advancements, coupled with government initiatives to improve healthcare infrastructure in the region, further fuel market expansion. However, challenges remain, including high costs associated with advanced devices, limited access to healthcare in certain regions, and a shortage of skilled surgeons, potentially hindering market growth in some areas. The market is segmented by product type (handheld devices, laparoscopic devices, electrosurgical devices, etc.), application (gynecology, cardiology, orthopedics, etc.), and geography (GCC, South Africa, Rest of MEA). Major players like B. Braun Melsungen AG, Johnson & Johnson, and Medtronic PLC are strategically investing in research and development, along with expanding their distribution networks across the MEA region, to capitalize on the market's growth potential. The segmentation within the MEA General Surgical Devices market reveals varied growth prospects. The laparoscopic devices segment is anticipated to experience significant growth due to its minimally invasive nature and enhanced precision. Similarly, the demand for electrosurgical devices is increasing due to their versatile application across various surgical procedures. Geographically, the GCC region is projected to hold a larger market share driven by robust healthcare infrastructure and high disposable incomes. However, South Africa and the Rest of MEA are also anticipated to witness considerable growth fueled by increasing investments in healthcare and rising awareness about advanced surgical techniques. Competition among key players is intense, with companies focusing on product innovation, strategic partnerships, and mergers and acquisitions to maintain a strong market position. This dynamic interplay between technological advancements, market segmentation, and competitive landscape shapes the future trajectory of the MEA General Surgical Devices market. Recent developments include: In October 2022, Alameda Healthcare Group launched the center of excellence for minimally invasive and robotics surgery in collaboration with Cambridge Medical Robotics Systems (CMR), elevating Egypt's healthcare sector and revolutionizing surgical procedures by introducing CMR's latest innovative technology, the Versius robotic surgical system., In October 2022, Saudi German Health showcased its transformation journey. It highlighted its developments and innovations in Saudi Arabia's healthcare sector during the Global Health Exhibition 2022 under the booth's theme of 'Caring Like Family.' This exhibition aimed to introduce new medical and healthcare devices in Saudi Arabia, with a commitment to improvising Saudi Arabia's healthcare infrastructure.. Key drivers for this market are: Rising Demand for Minimally Invasive Devices, Growing Cases of Injuries and Accidents. Potential restraints include: Rising Demand for Minimally Invasive Devices, Growing Cases of Injuries and Accidents. Notable trends are: Handheld Devices are Expected to Witness Significant Growth over the Forecast Period.

The Middle East and Africa Hospital Supplies Market is segmented by Type (Patient Examination Devices, Operating Room Equipment, Mobility Aids and Transportation Equipment, Sterilization and Disinfectant Equipment, Disposable Hospital Supplies, Syringes and Needles, and Other Types) and Country (GCC, South Africa, Rest of Middle East and Africa). The report offers the value (in USD million) for the above segments.

Sales of syringes and needles in GCC are set to rise at a 5.40% CAGR through 2034. Demand outlook for syringes and needles in GCC indicates crossing US$ 688.5 million in 2024. By 2034, sales projections for syringes and needles in GCC signify attaining a valuation of US$ 1,164.90 million.

Attributes	Details
Industry Size of GCC in 2024	US$ 688.5 million
Expected Industry Size of GCC in 2034	US$ 1,164.90 million
Forecasted CAGR between 2024 to 2034	5.40%

Category-wise insights

Leading Product for Syringes and Needles in GCC	Hypodermic
Total Value Share (2024)	85.40%

Leading Usability for Syringes and Needles in GCC	Disposable
Total Value Share (2024)	80.30%

Country-wise Insights

Countries	Value CAGR (2024 to 2034)
Kingdom of Saudi Arabia	5.60%
United Arab Emirates	5.70%
Qatar	5.50%
Bahrain	4.60%
Oman	5.30%

Scope of the Report

Attribute	Details
Estimated Industry Size in 2024	US$ 688.5 million
Projected Industry Size by 2034	US$ 1,164.90 million
Anticipated CAGR between 2024 to 2034	5.40% CAGR
Historical Analysis of Demand for Syringes and Needles in GCC	2019 to 2023
Demand Forecast for Syringes and Needles in GCC	2024 to 2034
Report Coverage	Industry Size, Industry Trends, Analysis of Key Factors Influencing Syringes and Needles in GCC , Insights on Global Players and their Industry Strategy in GCC, Ecosystem Analysis of Local and Regional GCC Manufacturers
Key Countries Analyzed while Studying Opportunities in Syringes and Needles in GCC	Kingdom of Saudi Arabia (KSA) United Arab Emirates (UAE) Qatar Bahrain Oman Kuwait
Key Companies Profiled	Becton, Dickinson and Company (BD) Terumo Corporation Smiths Medical Nipro Corporation B. Braun Melsungen AG Cardinal Health, Inc. Gerresheimer AG Hindustan Syringes & Medical Devices Ltd. (HMD) Medtronic plc Fresenius SE & Co. KGaA

The Middle East and Africa patient monitoring market is experiencing robust growth, projected to reach $2.20 billion in 2025 and expand at a Compound Annual Growth Rate (CAGR) of 5.80% from 2025 to 2033. This expansion is driven by several key factors. Increasing prevalence of chronic diseases like cardiovascular conditions and neurological disorders, coupled with a rising geriatric population, fuels demand for advanced monitoring technologies. Furthermore, improving healthcare infrastructure, particularly in the GCC region, and the increasing adoption of telehealth solutions are contributing to market growth. Government initiatives promoting healthcare access and technological advancements are also playing a significant role. The market is segmented by device type (hemodynamic, neuromonitoring, cardiac, multi-parameter, and others), application (cardiology, neurology, respiratory, fetal/neonatal, and others), and end-user (home healthcare, hospitals and clinics, and others). Hospitals and clinics currently dominate the end-user segment, owing to their existing infrastructure and expertise, while the home healthcare segment is poised for substantial growth due to technological advancements enabling remote patient monitoring. Competition within the market is intense, with major players like Abbott Laboratories, Boston Scientific, and Medtronic vying for market share through product innovation and strategic partnerships. While data for specific GCC, South African, and Rest of Middle East and Africa regional breakdowns are unavailable, the GCC region likely accounts for the largest portion of the market given its higher healthcare expenditure and technological adoption rates compared to other regions within the MEA. The future growth of the MEA patient monitoring market hinges on several trends. The increasing adoption of minimally invasive procedures and remote patient monitoring technologies is expected to further drive demand. Technological innovations such as AI-powered diagnostic tools and wearable patient monitoring devices will significantly influence market growth. Furthermore, the focus on improving affordability and accessibility of healthcare, particularly in underserved regions of Africa, will be instrumental in shaping the market trajectory. Potential restraints include regulatory hurdles, high costs associated with advanced technologies, and a lack of skilled healthcare professionals in some regions. However, ongoing investments in healthcare infrastructure and the growing awareness of the benefits of early disease detection and preventative care are projected to offset these challenges. The market offers attractive opportunities for manufacturers of innovative, cost-effective monitoring solutions, especially those that address the specific healthcare needs of diverse populations across the region. Recent developments include: In March 2022, BioIntelliSense Inc collaborated with Mubadala Health, the integrated healthcare network of Mubadala Investment company. This collaboration incorporated BioIntelluSense's innovative remote care technologies with Mubadala BiointelliSense's innovative remote care technologies with Mubadala Health's continuous care model to drive clinical workflow efficiencies., In March 2022 Cardo Health launched the telemedicine app Kena Health in South Africa. Kena Health targets the millions of uninsured citizens who are dependent on stressed public health systems using a B2C freemium business model.. Key drivers for this market are: Rising Burden of Chronic Diseases due to Lifestyle Changes, Growing Preference for Home and Remote Monitoring. Potential restraints include: Rising Burden of Chronic Diseases due to Lifestyle Changes, Growing Preference for Home and Remote Monitoring. Notable trends are: Hemodynamic Monitoring Devices Segment is Expected to Grow Fastest Over the Forecast Period.

The Saudi Arabian respiratory devices market is experiencing robust growth, driven by factors such as the rising prevalence of chronic respiratory diseases like asthma, COPD, and sleep apnea, coupled with an aging population and increasing healthcare expenditure. The market, valued at approximately $X million in 2025, is projected to witness a Compound Annual Growth Rate (CAGR) of 5.50% from 2025 to 2033. This growth is fueled by enhanced healthcare infrastructure, increased government initiatives promoting preventive healthcare, and rising awareness about respiratory health. The segment dominated by therapeutic devices, including CPAP, BiPAP machines, and inhalers, is expected to continue its strong performance due to the increasing need for effective treatment of chronic respiratory conditions. Growth in the diagnostic and monitoring segment, encompassing spirometers, pulse oximeters, and sleep test devices, is also anticipated, owing to improved diagnostic capabilities and early disease detection. The disposables segment, comprising masks and breathing circuits, will likely exhibit moderate growth, influenced by the demand for these consumables alongside the rising usage of therapeutic devices. Key players in the Saudi Arabian respiratory devices market include both multinational corporations like ResMed, Philips, and Medtronic, and local distributors. The market's competitive landscape is characterized by intense competition among these players, focusing on product innovation, technological advancements, and strategic partnerships to capture market share. Despite this growth, challenges remain, such as the high cost of advanced respiratory devices and the potential for inconsistent healthcare access across different regions within Saudi Arabia. Nevertheless, the overall outlook for the Saudi Arabian respiratory devices market remains positive, driven by sustained growth in demand and ongoing efforts to improve respiratory healthcare infrastructure and accessibility. (Note: Value of $X million for 2025 is assumed based on the provided information; specific market size data was not explicitly given). Recent developments include: In March 2022, Avon Protection demonstrated its respiratory and head protection portfolio, including Avon Protection's FM50 respirator, MP-PAPR, and the F90 helmet at the first World Defense Show in Riyadh, Saudi Arabia., In February 2022, Starpharma signed an exclusive sales and distribution agreement for antiviral nasal spray VIRALEZE in Saudi Arabia and eight other countries including the GCC region. VIRALEZE is now registered as a medical device.. Key drivers for this market are: Increasing Prevalence of Respiratory Disorders, Rising Government Initiatives and Large Patient Population. Potential restraints include: Increasing Prevalence of Respiratory Disorders, Rising Government Initiatives and Large Patient Population. Notable trends are: Inhalers Segment is Expected to Witness Growth Over the Forecast Period.

The size and share of this market is categorized based on Treatment Type (Wound Care Dressings, Debridement Devices, Therapeutic Footwear, Bioengineered Skin Substitutes, Other Treatments) and End-User (Hospitals, Home Healthcare, Specialty Clinics, Long-term Care Facilities, Others) and Distribution Channel (Direct Sales, Distributors, Online Sales, Retail Pharmacies, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, Middle-East and Africa).

The Middle East and Africa Nuclear Imaging Devices market is projected to reach $292.72 million in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 2.60% from 2025 to 2033. This growth is driven by several factors. Increasing prevalence of chronic diseases like cancer and cardiovascular ailments necessitates advanced diagnostic tools, fueling demand for nuclear imaging devices. Furthermore, rising healthcare expenditure in several Middle Eastern and African nations, coupled with government initiatives to improve healthcare infrastructure, is creating a favorable environment for market expansion. Technological advancements leading to more sophisticated and portable devices, as well as improved image quality and reduced radiation exposure, are further stimulating market growth. The adoption of PET/CT and SPECT/CT systems, offering combined anatomical and functional imaging capabilities, is a prominent trend. However, the market faces some restraints, including high equipment costs, the need for specialized personnel for operation and maintenance, and regulatory hurdles related to the handling of radioisotopes in certain regions. The market is segmented by product (equipment and radioisotopes) and application (SPECT and PET for various medical specialties like cardiology, oncology, and neurology) across key geographical areas like the Gulf Cooperation Council (GCC) nations, South Africa, and the rest of the Middle East and Africa. The GCC region, due to its higher healthcare infrastructure spending, is likely to dominate the market share. The competitive landscape features a mix of global and regional players, including established medical device manufacturers and radioisotope suppliers. Companies such as GE Healthcare, Siemens AG, and Bracco Imaging are key players leveraging their technological expertise and established distribution networks. However, the market also provides opportunities for smaller, specialized companies focusing on niche applications or regional markets. The market's future trajectory will depend on continued investment in healthcare infrastructure, the successful integration of new technologies, and addressing the challenges related to cost and regulatory compliance. While precise regional market share data is unavailable, we can logically infer that the GCC countries will hold a significantly larger share compared to South Africa and the rest of the MEA region given their higher healthcare expenditure and advanced medical facilities. Further expansion is expected to be driven by increasing awareness about the benefits of nuclear imaging techniques and improving access to healthcare services. Recent developments include: October 2022: Integrated Diagnostics Holdings PLC announced that its radiology venture, Al-Borg Scan, received the American College of Radiology accreditation for its nuclear medicine and ultrasound units., March 2022: The Arab States strengthed cooperation in nuclear medicine and science. The concurrent MoU signings were a first of their kind for ARASIA and enabled the most technically-advanced Arab countries to support their neighbors in nuclear medicine, calibration of instrumentation, and in dosimetry and ensuring safety from ionizing radiation.. Key drivers for this market are: Rise in Prevalence of Cancer and Cardiac Disorders, Growth in Applications of Nuclear Medicine and Imaging. Potential restraints include: Rise in Prevalence of Cancer and Cardiac Disorders, Growth in Applications of Nuclear Medicine and Imaging. Notable trends are: Oncology Segment is Expected to Grow at a Higher CAGR During the Forecast Period.

The MEA general surgical devices market exhibits robust growth, projected to reach a market size of XX million by 2025, expanding at a CAGR of 11.80% from 2025 to 2033. This significant expansion is propelled by several key drivers. The increasing prevalence of chronic diseases like diabetes and cardiovascular issues necessitates more surgical interventions, fueling demand. Rising healthcare expenditure, particularly in the GCC region, coupled with improving healthcare infrastructure across the MEA, contributes significantly to market growth. Furthermore, technological advancements in minimally invasive surgical techniques, such as laparoscopy and robotic surgery, are driving adoption of sophisticated devices. Growing awareness about advanced surgical procedures and their benefits among both patients and healthcare professionals also play a crucial role. Key market trends include the increasing preference for single-use surgical devices to mitigate infection risks and the rising adoption of telehealth and remote patient monitoring, impacting the aftercare and follow-up aspects of surgical procedures. However, the market faces certain restraints, including high costs associated with advanced surgical devices, limited healthcare infrastructure in certain regions of the MEA, and regulatory hurdles in obtaining approvals for new technologies. Segmentation reveals a strong demand across various product categories, including handheld devices, laparoscopic devices, and electro surgical devices, with significant applications in gynecology and urology, cardiology, and orthopedics. Geographical analysis shows the GCC countries contributing the largest share, followed by South Africa, with the rest of the MEA region also showing considerable growth potential. Major players such as Smith & Nephew PLC, Becton Dickinson and Company (BD), Siemens AG, 3M Company, Medtronic PLC, General Electric Company (GE Healthcare), Olympus Corporations, Canon Medical Systems Corporation, Johnson & Johnson, B Braun Melsungen AG, and Integer Holdings Corporation dominate the market, competing through product innovation, strategic partnerships, and geographical expansion. The GCC region's strong economic growth and supportive government initiatives focusing on healthcare infrastructure development drive market expansion within the region. South Africa, with its relatively developed healthcare system, also presents a lucrative market segment. The "Rest of Middle East and Africa" segment exhibits considerable growth potential, driven by rising disposable incomes, improving access to healthcare, and increased awareness regarding surgical solutions. The forecast period (2025-2033) anticipates continued market expansion, primarily fueled by the ongoing adoption of minimally invasive surgical techniques, increasing prevalence of target diseases, and the proactive efforts of market players to enhance their product offerings and penetrate new markets. However, the market's trajectory remains sensitive to factors like economic fluctuations, healthcare policy changes, and the successful implementation of innovative surgical devices and technologies across the diverse healthcare landscapes within the MEA region. Recent developments include: In October 2022, Alameda Healthcare Group launched the center of excellence for minimally invasive and robotics surgery in collaboration with Cambridge Medical Robotics Systems (CMR), elevating Egypt's healthcare sector and revolutionizing surgical procedures by introducing CMR's latest innovative technology, the Versius robotic surgical system., In October 2022, Saudi German Health showcased its transformation journey. It highlighted its developments and innovations in Saudi Arabia's healthcare sector during the Global Health Exhibition 2022 under the booth's theme of 'Caring Like Family.' This exhibition aimed to introduce new medical and healthcare devices in Saudi Arabia, with a commitment to improvising Saudi Arabia's healthcare infrastructure.. Key drivers for this market are: Rising Demand for Minimally Invasive Devices, Growing Cases of Injuries and Accidents. Potential restraints include: Stringent Government Regulations, Improper Reimbursement for Surgical Devices. Notable trends are: Handheld Devices are Expected to Witness Significant Growth over the Forecast Period.

The GCC ICT Market report segments the industry into By Technology (Big Data Analytics, Mobility and Telecom, Cloud Computing, Storage, Business Process Outsourcing, Other Technologies), By Component (Hardware/Devices, Software and Services, Communication and Connectivity), By End-User Industry (Oil, Gas and Utilities, Travel and Hospitality, Healthcare, Financial Services, and more), and By Country.

The GCC Flexible Packaging Market report segments the industry into By Material Type (Plastic, Paper, Metal), By Product Type (Bags and Pouches, Films and Wraps, Other Product Types), By End-user Industry (Food, Beverage, Pharmaceutical and Medical, Household and Personal Care, Other End-user Industries), and By Country (Saudi Arabia, United Arab Emirates, Qatar).

In 2023, eight of the Middle East’s top healthcare brands had a brand value of at least 150 million U.S. dollars each. King Faisal Specialist Hospital and Research Center (KFSH&RC) in Saudi Arabia was the leading healthcare brand in the region, valued at more than one billion U.S. dollars. Nahdi, which was the third largest healthcare brand in terms of value, was also the leading health and pharmaceutical retailer in the Middle East and Africa in terms of revenue and is expected to maintain this lead in the coming years.

Healthcare brands in the Middle East

These healthcare brands serve a wide range of consumer and patient needs. Nahdi and Al Dawaa are pharmaceutical retailers, whereas KFSH&RC and Dallah Health both operate healthcare facilities and academic research centers. Additionally, Dallah Health also provides pharmaceutical distribution and logistics, having one of the highest market capitalizations of healthcare brands in Saudi Arabia following Dr. Sulaiman Al Habib Medical Services Group and Mouwasat Medical Services Company. More than 85 percent of Mouwasat’s revenue of 2.3 billion U.S. dollars in 2022 was from medical services, while the remaining was from pharmaceuticals.

Health market in the Middle East

The healthcare industry in the Middle East is rapidly growing. Consumer healthcare spending in the United Arab Emirates, one of the region’s largest economies, is expected to witness consistent growth, surpassing 14 billion U.S. dollars by 2029. Other nations in the region are forecast to record similar growth in consumer spending on healthcare. Consumer health sales in Saudi Arabia has already surpassed seven percent of its e-commerce market in recent years. In addition to traditional health services and products, there has been a rise in digital healthcare in the Gulf Cooperation Council countries, with Saudi Arabia leading the region in revenue.

The Middle East and Africa nuclear imaging devices market is projected to exhibit a CAGR of 2.60% during the forecast period 2025 - 2033. The market is estimated to reach a value of 397.27 million by 2033, growing from 292.72 million in 2025. Key drivers of this growth include the increasing prevalence of chronic diseases, technological advancements, and the growing adoption of nuclear medicine techniques for diagnostic and therapeutic purposes. The high cost of equipment and lack of skilled professionals pose challenges to market growth. The equipment segment held the largest market share in 2025, and is expected to continue to dominate throughout the forecast period. The increasing adoption of advanced imaging technologies, such as PET/CT and SPECT/CT, is driving the growth of this segment. The radioisotope segment is also expected to witness significant growth due to the increasing demand for radioisotopes for diagnostic and therapeutic procedures. Geographically, the GCC region is expected to be the largest market for nuclear imaging devices, followed by South Africa and the Rest of Middle East and Africa. The increasing investment in healthcare infrastructure and the growing awareness of nuclear medicine in these regions are key factors contributing to this growth. Recent developments include: October 2022: Integrated Diagnostics Holdings PLC announced that its radiology venture, Al-Borg Scan, received the American College of Radiology accreditation for its nuclear medicine and ultrasound units., March 2022: The Arab States strengthed cooperation in nuclear medicine and science. The concurrent MoU signings were a first of their kind for ARASIA and enabled the most technically-advanced Arab countries to support their neighbors in nuclear medicine, calibration of instrumentation, and in dosimetry and ensuring safety from ionizing radiation.. Key drivers for this market are: Rise in Prevalence of Cancer and Cardiac Disorders, Growth in Applications of Nuclear Medicine and Imaging. Potential restraints include: Stringent RegulatIons, Reimbursement Issues. Notable trends are: Oncology Segment is Expected to Grow at a Higher CAGR During the Forecast Period.

The GCC In Vitro Diagnostics (IVD) market, valued at approximately $2.07 billion in 2025, is projected to experience robust growth, driven by factors such as increasing prevalence of chronic diseases (diabetes, cancer, cardiovascular conditions), rising healthcare expenditure, and growing adoption of advanced diagnostic techniques. The market's Compound Annual Growth Rate (CAGR) of 5.10% from 2025 to 2033 indicates a significant expansion, exceeding the global average for several key segments. This growth is fueled by the increasing awareness of early disease detection and prevention strategies within the GCC region, leading to higher demand for accurate and efficient diagnostic tools. Key segments such as point-of-care diagnostics and molecular diagnostics are expected to witness faster growth rates than the overall market, driven by technological advancements offering rapid and precise results, improving patient care and operational efficiencies in healthcare settings. The dominance of large multinational corporations such as Abbott Laboratories, Roche, and Siemens Healthineers underscores the market's maturity and the preference for high-quality, reliable products within the region. However, challenges remain, including regulatory hurdles for new technologies and variations in healthcare infrastructure across different GCC countries. Despite these challenges, the positive demographic trends, increasing investments in healthcare infrastructure, and government initiatives supporting disease prevention are expected to propel the market toward sustained growth in the forecast period. The increasing adoption of telehealth and remote diagnostics is also anticipated to contribute to the expansion of the market, particularly in the point-of-care segment. The market segmentation reveals significant opportunities across various applications. Infectious diseases diagnostics will likely remain a major segment due to the region's climatic conditions and population density, while the growing prevalence of chronic diseases like diabetes and cancer will drive substantial growth in these specific application segments. The preference for technologically advanced diagnostic instruments and reagents over simpler products will also contribute to the overall market expansion. Hospitals and clinics will remain major end-users, however, the development of portable and user-friendly diagnostic devices will fuel growth in the point-of-care diagnostics segment, catering to smaller clinics and even home-based testing in specific applications like diabetes management. The presence of established players and significant foreign direct investment in the healthcare sector further reinforce the market's positive outlook. Recent developments include: July 2022: Saudi Arabia's Arabian International Healthcare Holding Company, TIBBIYAH, commenced a new Joint Venture (JV) with Swiss company Unilabs Diagnostics AB., April 2022: United Arab Emirates Sheikh Shakhbout Medical City (SSMC), one of the first hospitals in the Middle East to launch a prominent point-of-care tool for antimicrobial management.. Key drivers for this market are: Growing Burden of Chronic Diseases and Infectious Diseases, Increasing Healthcare Expenditure. Potential restraints include: Stringent Regulations. Notable trends are: Point-of-care diagnostics Segment is Expected to Witness Growth Over The Forecast Period..

The Gulf Cooperation Council (GCC) In Vitro Diagnostic (IVD) market is projected to reach $674.52 million by 2033, growing at a CAGR of 7.92% from 2025 to 2033. The growth of the market is primarily driven by the increasing prevalence of chronic diseases, such as cancer and diabetes, in the region, as well as the growing demand for accurate and timely diagnostic services. Key trends influencing the market include the rising adoption of molecular diagnostics, the increasing use of point-of-care diagnostics, and the growing demand for personalized medicine. Competitive landscape: Danaher Corporation, Siemens Healthineers, Quidel Corporation, Johnson and Johnson, Thermo Fisher Scientific, Hologic, Abbott Diagnostics, Agilent Technologies, bioMérieux, Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Becton Dickinson and Company, PerkinElmer, F. HoffmannLa Roche have significant market shares in the GCC IVD market. These companies are continuously investing in research and development to offer innovative products and solutions to meet the evolving needs of healthcare providers and patients in the region. Recent developments include: Recent developments in the Global Gulf Cooperation Council (GCC) In Vitro Diagnostic Market have been marked by significant advancements in technology and increasing investments from leading companies. Danaher Corporation and Thermo Fisher Scientific are capitalizing on the rising demand for precision diagnostics, enhancing their product portfolios through innovative solutions. Siemens Healthineers is expanding its footprint in the region by collaborating with local healthcare providers to improve accessibility to advanced diagnostic tools. Meanwhile, Merger and acquisition activity remains notable, with Johnson & Johnson acquiring emerging diagnostic technology firms to strengthen its competitive edge. Abbott Diagnostics and bioMérieux are also investing in regional partnerships to facilitate rapid testing capabilities, particularly in response to ongoing health concerns. Moreover, the market is experiencing growth in valuation driven by the increasing prevalence of chronic diseases, which necessitates reliable diagnostic solutions. Companies like Hologic and Quidel Corporation are focusing on expanding their distribution networks in GCC countries, ensuring enhanced availability of their products. This growth trajectory is impacting the market positively, fostering innovation and propelling the overall demand for In Vitro Diagnostic solutions in the GCC region.. Key drivers for this market are: Growing demand for point-of-care testing, Increasing prevalence of chronic diseases; Advancements in molecular diagnostic technologies; Rising healthcare expenditure; Expanding geriatric population. Potential restraints include: Increasing prevalence of chronic diseases, Growing demand for rapid diagnostics; Technological advancements in IVD products; Rising healthcare expenditure; Regulatory support for innovation.